Madison El-Saadi
Stock Analyst at B. Riley Securities
(2.87)
# 1,580
Out of 5,135 analysts
13
Total ratings
46.15%
Success rate
13.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $63.69 | +58.58% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $6.20 | +125.81% | 2 | Dec 31, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $21 → $50 | $23.06 | +116.83% | 2 | Dec 15, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $12.59 | +193.88% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $183.30 | -2.35% | 1 | Oct 1, 2025 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $24 → $26 | $17.15 | +51.60% | 3 | May 16, 2025 |
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $63.69
Upside: +58.58%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $6.20
Upside: +125.81%
Capricor Therapeutics
Dec 15, 2025
Reiterates: Buy
Price Target: $21 → $50
Current: $23.06
Upside: +116.83%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $12.59
Upside: +193.88%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $183.30
Upside: -2.35%
Eton Pharmaceuticals
May 16, 2025
Reiterates: Buy
Price Target: $24 → $26
Current: $17.15
Upside: +51.60%